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FIGURE 1 – Rapid Cycle Plan-Do-Study-Act methodology [16] 
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Retrospective analysis of patient admission and mortality data. 
Cumulative score of ≥3 selected as trigger for intervention
INTEGRATION OF 
PROGNOSTIC 
SCREENING INTO 
ROUTINE 
ASSESMENT
PLAN/DO: Staff informed of prognostic criteria, and criteria displayed on wall chart
STUDY/ACT: Prognostic scoring not routinely considered or completed following random audit
PLAN/DO: Prognostic screening added to agenda for discussion at weekly hepatology MDT
STUDY/ACT: Junior staff not confident in completing scoring (e.g. uncertainty re performance 
score)
PLAN/DO: Objective guidelines for scoring printed as single sheet and made available to junior 
staff
STUDY/ACT: Inconsistent documentation of discussions
PLAN/DO: MDT proforma with integrated prognostic screening(completion guidelines on back)
STUDY/ACT: Nursing staff - difficulty locating documentation within large volumes of medical 
notes
PLAN/DO: MDT proforma sheets coloured blue so easily identfied
STUDY/ACT: MDT documentation mass printed and completed for each patient during MDT
PLAN/DO: Prognostic screening and MDT documentation standardised forhepatology inpatients
STUDY/ACT: Random audit demonstrated completion rate of 89%.  Proforma adopted.
PLAN/DO: Introduction of prognostic screening identified inpatients with poor prognosis
STUDY/ACT: Patients/families not routinely informed of prognosis or stage of disease prior to 
discharge
PLAN/DO: Consultant discussion with patient & family prior to discharge when criteria met
STUDY/ACT: Difficult conversations surrounding uncertain trajectory in a complex patient group
PLAN/DO: Communication skills training delivered to hepatology staff by palliative care team
STUDY/ACT: GPs not routinely involved or included in discussions & unaware of progression
PLAN/DO: GP poor prognosis letter template produced & completed for each appropriate patient
STUDY/ACT: Complex palliative care needs identified during prognostic discussions
PLAN/DO: Palliative care consultation offered to patients with complex symptomatic/psychosocial 
needs + links to community services and opportunities for advance care planning
STUDY/ACT: Difficulties with continuity of care following discharge
PLAN/DO: Hepatology specialist nurse allocated for each patient, with contact details made 
available
STUDY/ACT: Above features combined and formalised as the ‘supportive care intervention’
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INPATIENTS WITH CIRROSIS
Childs Pugh C
> 2 liver related admissions last 6/12
Ongoing alcohol use in known ArLD
Currently unsuitable for transplantation
WHO performance status 3-4
SCORE ≥ 3
SUPPORTIVE CARE INTERVENTION
Consultant led poor prognosis discussion
Poor prognosis letter to GP
Opportunity for advance care planning
Specialist palliative care review if complex 
symptomatic/social/psychological needs
Allocation of hepatology specialist nurse
FIGURE 2 - Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle PDSA methodology
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FIGURE 3 - Integration of prognostic screening into weekly hepatology MDT proforma, completed weekly for each hepatology inpatient at University 
Hospitals Bristol Trust (front and reverse of sheet) 
 
 
 
 
 
 
 
 
 
  
